Reference ranges of serum IGF-1 and IGFBP-3 levels in a general adult population: Results of the Study of Health in Pomerania (SHIP)

Growth Hormone and IGF Research

Volumn 18, Issue 3, 2008, Pages 228-237

  Friedrich, Nele ^a   Alte, Dietrich ^a   Völzke, Henry ^a   Spilcke Liss, Elisabeth ^a   Lüdemann, Jan ^a   Lerch, Markus M ^a   Kohlmann, Thomas ^a   Nauck, Matthias ^a   Wallaschofski, Henri ^a  

^a UNIVERSITY OF GREIFSWALD   (Germany)

Author keywords

IGF 1; IGFBP 3; Quantile regression; References ranges; Study of Health in Pomerania (SHIP)

Indexed keywords

SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C;

ADULT; AGED; ARTICLE; CHEMOLUMINESCENCE; FEMALE; GERMANY; HEALTH SURVEY; HUMAN; HUMAN EXPERIMENT; IMMUNOASSAY; INTERMETHOD COMPARISON; LINEAR REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; NORMAL DISTRIBUTION; NORMAL HUMAN; POPULATION RESEARCH; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; REFERENCE VALUE; REGRESSION ANALYSIS;

ADULT; AGED; AGING; FEMALE; GERMANY; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 3; INSULIN-LIKE GROWTH FACTOR I; MALE; MIDDLE AGED; REFERENCE VALUES; REGRESSION ANALYSIS; SEX CHARACTERISTICS;

EID: 41649096728     PISSN: 10966374     EISSN: 15322238     Source Type: Journal    
DOI: 10.1016/j.ghir.2007.09.005     Document Type: Article

References (38)

1. Jones J.I., and Clemmons D.R. Insulin-like growth factors and their binding proteins: biological actions. Endocr. Rev. 16 (1995) 3-34
2. T.G.H.R. Society, Consensus guidelines for the diagnosis and treatment of growth hormone (GH) deficiency in childhood and adolescence: summary statement of the GH Research Society, The J. Clin. Endocrinol. Metab. 85 (2000) 3990-3993.
3. Shalet S.M., Toogood A., Rahim A., and Brennan B.M. The diagnosis of growth hormone deficiency in children and adults. Endocr. Rev. 19 (1998) 203-223
4. Brabant G. Insulin-like growth factor-I: marker for diagnosis of acromegaly and monitoring the efficacy of treatment. Eur. J. Endocrinol. 148 Suppl. 2 (2003) S15-S20
5. Ferone D., Resmini E., Bocca L., Giusti M., Barreca A., and Minuto F. Current diagnostic guidelines for biochemical diagnosis of acromegaly. Minerva Endocrinol. 29 (2004) 207-223
6. Consensus guidelines for the diagnosis and treatment of adults with growth hormone deficiency: summary statement of the Growth Hormone Research Society Workshop on Adult Growth Hormone Deficiency, The J. Clin. Endocrinol. Metab. 83 (1998) 379-381.
7. Vasan R.S., Sullivan L.M., D'Agostino R.B., et al. Serum insulin-like growth factor I and risk for heart failure in elderly individuals without a previous myocardial infarction: the Framingham Heart Study. Ann. Intern. Med. 139 (2003) 642-648
8. Juul A., Scheike T., Davidsen M., Gyllenborg J., and Jorgensen T. Low serum insulin-like growth factor I is associated with increased risk of ischemic heart disease: a population-based case-control study. Circulation 106 (2002) 939-944
9. Laughlin G.A., Barrett-Connor E., Criqui M.H., and Kritz-Silverstein D. The prospective association of serum insulin-like growth factor I (IGF-I) and IGF-binding protein-1 levels with all cause and cardiovascular disease mortality in older adults: the Rancho Bernardo Study. The J. Clin. Endocrinol. Metab. 89 (2004) 114-120
10. Renehan A.G., Zwahlen M., Minder C., O'Dwyer S.T., Shalet S.M., and Egger M. Insulin-like growth factor (IGF)-I, IGF binding protein-3, and cancer risk: systematic review and meta-regression analysis. Lancet 363 (2004) 1346-1353
11. Geusens P.P., and Boonen S. Osteoporosis and the growth hormone-insulin-like growth factor axis. Horm. Res. 58 Suppl. 3 (2002) 49-55
12. Goodwin P.J., Ennis M., Pritchard K.I., et al. Insulin-like growth factor binding proteins 1 and 3 and breast cancer outcomes. Breast Cancer Res. Treat. 74 (2002) 65-76
13. Niu T., and Rosen C.J. The insulin-like growth factor-I gene and osteoporosis: a critical appraisal. Gene 361 (2005) 38-56
14. Juul A., Bang P., Hertel N.T., et al. Serum insulin-like growth factor-I in 1030 healthy children, adolescents, and adults: relation to age, sex, stage of puberty, testicular size, and body mass index. The J. Clin. Endocrinol. Metab. 78 (1994) 744-752
15. Landin-Wilhelmsen K., Lundberg P.A., Lappas G., and Wilhelmsen L. Insulin-like growth factor I levels in healthy adults. Horm. Res. 62 Suppl. 1 (2004) 8-16
16. Elmlinger M.W., Kuhnel W., Weber M.M., and Ranke M.B. Reference ranges for two automated chemiluminescent assays for serum insulin-like growth factor I (IGF-I) and IGF-binding protein 3 (IGFBP-3). Clin. Chem. Lab. Med. 42 (2004) 654-664
17. Kehinde E.O., Akanji A.O., Mojiminiyi O.A., et al. Reference intervals for important serum sex steroid hormones, prostate-antigen, insulin-like growth factor-1 and IGF binding protein-3 concentration in a normal Kuwaiti adult male population. Med. Princ. Pract. 14 (2005) 342-348
18. Tiryakioglu O., Kadiolgu P., Canerolgu N.U., and Hatemi H. Age dependency of serum insulin - like growth factor (IGF)-1 in healthy Turkish adolescents and adults. Ind. J. Med. Sci. 57 (2003) 543-548
19. Kaklamani V.G., Linos A., Kaklamani E., Markaki I., and Mantzoros C. Age, sex, and smoking are predictors of circulating insulin-like growth factor 1 and insulin-like growth factor-binding protein 3. J. Clin. Oncol. 17 (1999) 813-817
20. Lofqvist C., Andersson E., Gelander L., Rosberg S., Blum W.F., and Albertsson Wikland K. Reference values for IGF-I throughout childhood and adolescence: a model that accounts simultaneously for the effect of gender, age, and puberty. The J. Clin. Endocrinol. Metab. 86 (2001) 5870-5876
21. Löfqvist C., Andersson E., Gelander L., et al. Reference values for insulin-like growth factor-binding protein-3 (IGFBP-3) and the ratio of insulin-like growth factor-I to IGFBP-3 throughout childhood and adolescence. The J. Clin. Endocrinol. Metab. 90 (2005) 1420-1427
22. Bereket A., Turan S., Omar A., et al. Serum IGF-I and IGFBP-3 levels of Turkish children during childhood and adolescence: establishment of reference ranges with emphasis on puberty. Horm. Res. 65 (2006) 96-105
23. Brabant G., von zur Muhlen A., Wuster C., et al. Serum insulin-like growth factor I reference values for an automated chemiluminescence immunoassay system: results from a multicenter study. Horm. Res. 60 (2003) 53-60
24. Ranke M.B., Osterziel K.J., Schweizer R., et al. Reference levels of insulin-like growth factor I in the serum of healthy adults: comparison of four immunoassays. Clin. Chem. Lab. Med. 41 (2003) 1329-1334
25. Koenker R. Quantile Regression. Econometric Society Monograph Series (2005), Cambridge University Press, New York
26. John U., Greiner B., Hensel E., et al. Study of health in Pomerania (SHIP): a health examination survey in an east German region: objectives and design. Soz Praventivmed 46 (2001) 186-194
27. Keil U., Stieber J., Doring A., et al. The cardiovascular risk factor profile in the study area Augsburg. Results from the first MONICA survey 1984/85. Acta Med. Scand. Suppl. 728 (1988) 119-128
28. Schneider H.J., Saller B., Klotsche J., et al. Opposite associations of age-dependent insulin-like growth factor-I standard deviation scores with nutritional state in normal weight and obese subjects. Eur. J. Endocrinol. 154 (2006) 699-706
29. Lundberg V., Tolonen H., Stegmayr B., Kuulasmaa K., and Asplund K. Use of oral contraceptives and hormone replacement therapy in the WHO MONICA project. Maturitas 48 (2004) 39-49
30. Gesundheitsberichterstattung des Bundes: http://www.gbe-bund.de/.
31. Hindmarsh P.C., Dennison E., Pincus S.M., et al. A sexually dimorphic pattern of growth hormone secretion in the elderly. The J. Clin. Endocrinol. Metab. 84 (1999) 2679-2685
32. Heald A., Selby P.L., White A., and Gibson J.M. Progestins abrogate estrogen-induced changes in the insulin-like growth factor axis. Am. J. Obstet. Gynecol. 183 (2000) 593-600
33. Kam G.Y., Leung K.C., Baxter R.C., and Ho K.K. Estrogens exert route- and dose-dependent effects on insulin-like growth factor (IGF)-binding protein-3 and the acid-labile subunit of the IGF ternary complex. The J. Clin. Endocrinol. Metab. 85 (2000) 1918-1922
34. Chin E., Zhou J., Dai J., Baxter R.C., and Bondy C.A. Cellular localization and regulation of gene expression for components of the insulin-like growth factor ternary binding protein complex. Endocrinology 134 (1994) 2498-2504
35. Scharf J.G., Ramadori G., Braulke T., and Hartmann H. Cellular localization and hormonal regulation of biosynthesis of insulin-like growth factor binding proteins and of the acid-labile subunit within rat liver. Prog. Growth Factor Res. 6 (1995) 175-180
36. Buchinsky M. Recent Advances in Quantile Regression Models: A Practical Guidline for Empirical Research. J. Hum. Resour. 33 (1998)
37. Gannoun A., Girard S., Guinot C., and Saracco J. Reference curves based on non-parametric quantile regression. Stat. Med. 21 (2002) 3119-3135
38. Pokrajac A., Wark G., Ellis A.R., Wear J., Wieringa G.E., and Trainer P.J. Variation in GH and IGF-I assays limits the applicability of international consensus criteria to local practice. Clin. Endocrinol. 67 (2007) 65-70